ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

BVXV BiondVax Pharmaceuticals Ltd

1.36
0.00 (0.00%)
Apr 25 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
BiondVax Pharmaceuticals Ltd BVXV NASDAQ Depository Receipt
  Price Change Price Change % Share Price Last Trade
0.00 0.00% 1.36 19:00:00
Open Price Low Price High Price Close Price Previous Close
1.36 1.36
more quote information »

Recent News

Date Time Source Heading
4/16/202416:27EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
4/10/202406:00PRNUSScinai to showcase its novel biological local therapeutic..
3/12/202415:17EDGAR2Form SC 13D - General statement of acquisition of beneficial..
3/12/202407:00PRNUSScinai leadership to attend BIO-Europe Spring 2024
2/13/202406:00PRNUSScinai Welcomes Liat Halpert as Head of Business Development..
1/04/202415:01PRNUSScinai Immunotherapeutics Announces Closing of Exercise of..
11/20/202306:30PRNUSScinai Immunotherapeutics Regains Compliance with Nasdaq's..
9/07/202316:27EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
9/06/202311:01EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
9/06/202310:44EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
9/06/202305:00GLOBEBiondVax Pharmaceuticals Ltd. Rebrands as Scinai..
8/28/202315:01EDGAR2Form 424B2 - Prospectus [Rule 424(b)(2)]
8/27/202323:15EDGAR2Form EFFECT - Notice of Effectiveness
8/24/202315:05EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
8/23/202305:10EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
8/18/202315:16EDGAR2Form F-3 - Registration statement by foreign private issuers
8/18/202309:07EDGAR2Form 6-K/A - Report of foreign issuer [Rules 13a-16 and..
8/14/202305:08EDGAR2Form 6-K/A - Report of foreign issuer [Rules 13a-16 and..
8/11/202308:44EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
8/11/202308:00GLOBEBiondVax Reports Second Quarter Financial Results and..
8/01/202315:01GLOBENasdaq Grants BiondVax Extension to Regain Compliance with..
8/01/202315:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
7/12/202314:10EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
7/11/202307:17GLOBEIBN Announces Latest Episode of The Bell2Bell Podcast..
7/05/202308:17EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
7/03/202315:10EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
7/03/202315:05EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
6/05/202306:00GLOBEBiondVax signs exclusive license agreement for development..

Your Recent History

Delayed Upgrade Clock